Baihua Pharmaceuticals: The controlling shareholder is planning to transfer shares, and the company's stock will be suspended from trading.

Baohua Pharmaceuticals announced that the controlling shareholder of the company, Mi Zaizi, Mi Enhua, and Yang Xiaoling are planning to transfer their shares through an equity transfer agreement, which may result in a change in the company's controlling rights. As this matter is still uncertain, in order to protect the interests of investors and avoid abnormal fluctuations in the stock price, the company's stock will be suspended from trading starting from December 29, 2025, for a period not exceeding 2 trading days. During the suspension period, the company will disclose any progress and resume trading promptly once the situation is clarified.